SDZ-89-104

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameSDZ-89-104
Drug Alias NameSDZ-89-109SDZ-89-104
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus InfectionsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSandoz Ltd
Active IndicationsN/A
Inactive IndicationsCytomegalovirus InfectionsHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A
Related LinksN/A